Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_assertion type Assertion NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_head.
- NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_assertion description "[MTR was measured in the SN of patients with CMT type 1A (CMT1A, n = 10), CMT type 2A (CMT2A, n = 3), hereditary neuropathy with liability to pressure palsies (n = 3), and healthy controls (n = 21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_provenance.
- NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_assertion evidence source_evidence_literature NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_provenance.
- NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_assertion SIO_000772 25253751 NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_provenance.
- NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_assertion wasDerivedFrom befree-20150227 NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_provenance.
- NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_assertion wasGeneratedBy ECO_0000203 NP632303.RAP67MASslCP0yI1iifB7gIxudyv2t5dTGohDgF1WfCM4130_provenance.